Cafepharma Today

June 20 2025 - Gene therapy faces fresh uncertainty as two more top FDA officials depart
Gene therapy faces fresh uncertainty as two more top FDA officials depart
Eli Lilly (LLY) sees strong demand for Mounjaro in India
A longer ‘winter’: Public funding slowdown heightens pressure on biotech startups
Is DTC pharma advertising coming to an end?
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Verve Therapeutics Announces Positive Initial Data from the Heart-2 Phase 1b Clinical Trial of VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
Stock Titan
Monday, April 14, 2025 - 9:44am
tags:
Verve Therapeutics, clinical trials, VERVE-102, gene editing, cardiovascular disease
Sandoz files U.S. antitrust lawsuit against Amgen over arthritis drug
Investing.com
Monday, April 14, 2025 - 9:42am
tags:
Sandoz, antitrust, legal, Amgen, Enbrel, generics
Intuitive wins FDA clearance for single-port robotic surgery stapler
Medtech Dive
Monday, April 14, 2025 - 9:40am
tags:
medtehc, Intuitive Surgical, FDA, robotic surgery, surgical stapler
Pharma’s capital allocation could shift as tariffs threaten an already fragile profit model
Pharma Voice
Monday, April 14, 2025 - 9:39am
tags:
pharma industry, tariffs, Donald Trump, capital allocation
Amgen pads Imdelltra's case in tough-to-treat lung cancer subtype with phase 3 survival win
Fierce Pharma
Sunday, April 13, 2025 - 11:21pm
tags:
Amgen, Imdelltra, extensive-stage small cell lung cancer, clinical trials
Bristol Myers combo follows Roche, AstraZeneca immunotherapy rivals into first-line liver cancer
Fierce Pharma
Sunday, April 13, 2025 - 11:19pm
tags:
Bristol Myers Squibb, Opdivo, Yervoy, hepatocellular carcinoma, FDA
Jobevne (Bevacizumab) Gains FDA Nod, Biocon Expands US Oncology Biosimilars Portfolio
Xtalks
Sunday, April 13, 2025 - 11:15pm
tags:
Jobevne, bevacizumab-nwgd, Biocon Biologics, biosimilars, Avastin, cancer, FDA
This Pharma Company Is Betting Big On A Chinese Ozempic Rival
Forbes
Sunday, April 13, 2025 - 11:13pm
tags:
Kailera Therapuetics, obesity, China, R&D
After Hetlioz’s rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use
Fierce Pharma
Sunday, April 13, 2025 - 11:11pm
tags:
Hetlioz, Vanda Pharmaceuticals, jet lag disorder, FDA
The 5 largest biopharma layoffs of Q1 2025
BioSpace
Friday, April 11, 2025 - 11:47am
tags:
layoffs, Novartis, Galapagos, Bristol Myers Squibb, Merck, Gilead Sciences
As Pfizer backs out of hemophilia gene therapy space, CSL hopes Hemgenix is here to stay
Fierce Pharma
Friday, April 11, 2025 - 11:32am
tags:
Pfizer, gene therapy, hemophilia, hemophilia B, Hemgenix, CSL Behring
Why Amgen Hired An AI Head From Nike
Forbes
Friday, April 11, 2025 - 11:30am
tags:
Amgen, artificial intelligence
Argenx stays on a roll with Vyvgart, gaining FDA nod for at-home prefilled syringe
Fierce Pharma
Friday, April 11, 2025 - 11:27am
tags:
Argenx, Vyvgart, Vyvgart Hytrulo, FDA, myasthenia gravis
Tariff turmoil: Hospitals, device makers welcome pause, but fear long-term pain
Medtech Dive
Friday, April 11, 2025 - 11:25am
tags:
Medtech, hospitals, devices, healthcare providers, tariffs, Donald Trump
Seismic Therapeutic doses healthy subject cohort in Phase I trial of S-4321
Clinical Trials Arena
Friday, April 11, 2025 - 11:23am
tags:
Seismic Therapeutic, clinical trials, S-4321, autoimmune diseases
Market volatility compounds ‘already challenging’ year for biotech IPOs
Fierce Biotech
Friday, April 11, 2025 - 11:21am
tags:
biotech, IPOs, stock market, Donald Trump, tariffs
J&J reports analysis from Phase III trial of plaque psoriasis treatment
Clinical Trials Arena
Friday, April 11, 2025 - 11:20am
tags:
JNJ, clinical trials, plaque psoriasis, icotrokinra
Canada launches antitrust probe into Cigna's Express Scripts unit
Yahoo/Reuters
Friday, April 11, 2025 - 11:16am
tags:
Cigna, Express Scripts, antitrust, legal, Canada
41% of drug shortages span more than 2 years
Beckers Hospital Review
Friday, April 11, 2025 - 11:11am
tags:
drug shortages
Pharma’s US manufacturing moment: Where companies are making the biggest moves
Pharma Voice
Friday, April 11, 2025 - 11:09am
tags:
Donald Trump, tariffs, pharma stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline
Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.